Form CORRESP - Correspondence:
SEC Accession No. 0001213900-17-010230
Filing Date
2017-10-03
Accepted
2017-10-03 11:11:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 15987
  Complete submission text file 0001213900-17-010230.txt   16969
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations